Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(50%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

4

all time

Status Distribution
Active(2)
Completed(1)
Other(1)

Detailed Status

Recruiting2
unknown1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

recruiting250%
unknown125%
completed125%

Recent Activity

2 active trials
Showing 4 of 4
recruitingnot_applicable

Tolerance Profile of Soluble Fibers in Individuals With Self-perceived GI Sensitivity to Fibers (Tarine)

NCT06877013
recruitingnot_applicable

Dietary Approach to Mild-to-moderate Psoriasis

NCT05644782
completednot_applicable

Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo

NCT02472704
unknownnot_applicable

Repeat Dose Nasal Allergen Challenge

NCT01110837

Clinical Trials (4)

Showing 4 of 4 trials
NCT06877013Not Applicable

Tolerance Profile of Soluble Fibers in Individuals With Self-perceived GI Sensitivity to Fibers (Tarine)

Recruiting
NCT05644782Not Applicable

Dietary Approach to Mild-to-moderate Psoriasis

Recruiting
NCT02472704Not Applicable

Lymphocytic Enteritis and Suspected Coeliac Disease: Gluten vs Placebo

Completed
NCT01110837Not Applicable

Repeat Dose Nasal Allergen Challenge

Unknown

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4